Published reports
reportreportreport
GLP-1 and Incretin Landscape: From Ozempic to Triple Agonists
A strategic overview of approved and pipeline incretin-based peptide therapeutics.
Aug 15, 2024
Obesity Market Outlook: Supply, Pricing, and Next-Generation Assets
Commercial dynamics shaping the obesity therapeutic market through 2030.
Aug 10, 2024
Oral GLP-1 Competitive Assessment: Pills vs Injections
Evaluating oral peptide and small-molecule approaches in the GLP-1 class.
Aug 12, 2024